Andrea O’Shea

Pilot corpus only

This score is computed over theSindex pilot corpus and does not cover the full scientific literature. Scores are relative to papers we have ingested — papers, authors, and institutions outside the pilot are not represented. Methodology.

Top 100%percentile

0Author DataRank

Indexed papers

0in pilot corpus

datarank_citation_only_1hop_v6· scope data_onlyMethodology

Papers

Driven by 5 papers. Top paper: “Ovarian cancer cells direct monocyte differentiation through a non-canonical pathway”.

Ovarian cancer cells direct monocyte differentiation through a non-canonical pathway

BMC Cancer(2020)10.1186/s12885-020-07513-w

N/A

0DataRank · unranked

12 citations

Andrew Miller, Ying Li, Will Flanigan, Alyssa Walker, Andrea O’Shea +3 more

Ovarian Cancer Cells Direct Monocyte Differentiation Through a Non-canonical Pathway

Research Square(2020)10.21203/rs.3.rs-48995/v1

N/A

0DataRank · unranked

0 citations

Andrew Miller, Ying Li, Will Flanigan, Alyssa Walker, Andrea O’Shea +3 more

Ovarian Cancer Cells Direct Monocyte Differentiation Through A Non-Canonical Pathway

Research Square(2020)10.21203/rs.3.rs-48995/v2

N/A

0DataRank · unranked

0 citations

Andrew Miller, Ying Li, Will Flanigan, Alyssa Walker, Andrea O’Shea +3 more

Effect of External Beam Radiation Therapy and Brachytherapy on Circulating Myeloid-Derived Suppressor Cell Populations in Patients Treated Definitively for Cervical Cancer

Advances in Radiation Oncology(2024)10.1016/j.adro.2024.101677

N/A

0DataRank · unranked

0 citations

Matthew Berkseth, Nicole Sando, Lydia Golden, Amy Techam, J. Wieworka +13 more

Comparing Durvalumab, Olaparib, and Cediranib Monotherapy, Combination Therapy, or Chemotherapy in Patients with Platinum-Resistant Ovarian Cancer with Prior Bevacizumab: The Phase II NRG-GY023 Trial

Clinical Cancer Research(2025)10.1158/1078-0432.ccr-24-3877

N/A

0DataRank · unranked

8 citations

Austin Miller, Peter G. Rose, Mariam AlHilli, Christina Washington, Veena S. John +15 more